In a recent interview with AGORACOM, HPQ CEO Bernard Tourillon shares key insights on the company’s accelerated path to battery commercialization:
✅ HPQ has signed a new industrial agreement with Novacium, enabling the company to begin production of GEN3-based lithium-ion batteries in parallel with its French partner.
✅ HPQ is now targeting Q3 2025 for the North American launch of its own 18650 (4,000 mAh) and 21700 (6,000 mAh) high-performance battery cells.
✅ Novacium’s validated technology transfer allows seamless integration of GEN3 silicon-anode material into existing industrial production lines.
By watching the interview, you’ll learn:
▶ Why HPQ shifted to a concurrent production model
▶ How this move accelerates time-to-revenue and reduces commercialization risk
▶ What this partnership means for HPQ’s long-term battery production strategy in North America
Watch the full interview:
Want to Learn More?
If this interview piqued your interest and you want to dive deeper into the work we’re doing, make sure to read the related press release here.
Your continued support is vital in driving our mission forward, and we remain dedicated to keeping you informed about our ongoing projects and achievements.
HPQ Silicon is a Quebec-based TSX Venture Exchange Tier 1 Industrial Issuer. With the support of world-class technology partners PyroGenesis Canada and NOVACIUM SAS, the company is developing new green processes crucial to make the critical materials needed to reach net zero emissions.
